Early initiation of eculizumab therapy for Streptococcus pneumoniae –associated hemolytic uremic syndrome

All the authors whose names are listed above certify that they have no conflict of interest. They have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony, or patent-licensing arrangements), or nonfinancial interest (such as...